Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eye function, circadian rhythm, and ADHD study
NL-OMON55884Active, not recruiting
- Sponsor
- Parnassia Groep
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Parnassia Groep. Primary endpoints: Prevalence of refractive errors, Type and extent of refractive errors and 1 more. Started Oct 2016; status: active, not recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON55884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55884.